Pramipexole (Prami), 12 mg (0.2 mg/60 capsules)

Pramipexole, often known as Prami, is a benzothiazole derivative that selectively binds to D2, D3, and D4 dopamine receptors and acts as a high-affinity D2-like dopamine receptor agonist. At these receptor locations, it demonstrates strong intrinsic activity that affects different dopaminergic signaling pathways. This substance is mostly eliminated via renal excretion in its unaltered form, with little hepatic metabolism.